← Leaderboards
Charles S. Tannenbaum
Cleveland Clinic Lerner Col/Med-Cwru
$1,053,255
Attributed
$1,053,255
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $272K · FY2005–08$500K$375K$250K$125K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$1,053,255 · 1
By mechanism
R01$1,053,255 · 1
Top collaborators
No co-investigators on record.
Most similar at Cleveland Clinic Lerner Col/Med-Cwru
Same institution · by research overlap
- Peter M Chumakov$3,003,357
Others in their field
Top investigators on “Antibodies”
- Lawrence Corey · Fred Hutchinson Cancer Center$525,765,536
- Bambra Strokes · Ppd Development Lp$461,655,950
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$385,009,925
- Barton F Haynes · Duke University$372,611,596
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$323,573,074
- Dennis R. Burton · Scripps Research Institute$306,733,901
Research focus
AntibodiesApoptoticBaseApoptosisCaspase-8Cell DeathCell KillingCell LineCell Line, TumorBinding (Molecular Function)Cessation Of LifeCoculture TechniquesDefectEffectivenessEventFunctional DisorderGanglioside Gm1GangliosidesGenesGrowthCell MembraneImmune ResponseIn VitroJurkat Cells
Grant awards (4)
Tumor Gangliosides and TNF Synergize for T Cell Death$257,865
R01 · FY2008 · CA · contact PI
Tumor Gangliosides and TNF Synergize for T Cell Death$257,865
R01 · FY2007 · CA · contact PI
Tumor Gangliosides and TNF Synergize for T Cell Death$265,567
R01 · FY2006 · CA · contact PI
Tumor Gangliosides and TNF Synergize for T Cell Death$271,958
R01 · FY2005 · CA